Connecticut General Statutes
Chapter 420b - Dependency-Producing Drugs
Section 21a-256. (Formerly Sec. 19-463). - Labeling of package or container of controlled substances.

(a) When a manufacturer sells or dispenses a controlled substance and when a wholesaler sells, dispenses or distributes a controlled substance in a package prepared by him, he shall securely affix to each package in which that substance is contained a label showing in legible English the name and address of the vendor and the quantity, kind and form of controlled substance contained therein and any additional information required under the federal food and drug laws and the state food, drug and cosmetic laws. No person, except a practitioner dispensing a controlled substance under this chapter, shall alter, deface or remove any label so affixed.

(b) When a pharmacist sells or dispenses any controlled substance on prescription issued by a physician, advanced practice registered nurse, physician assistant, podiatrist, dentist or veterinarian, the pharmacist shall affix, to the container in which such substance is sold or dispensed, a label showing the name and address of the pharmacy for which the pharmacist is lawfully acting, the full name of the patient, or, if the patient is an animal, the name of the owner of the animal and the species of the animal, the last name of the physician, advanced practice registered nurse, physician assistant, podiatrist, dentist or veterinarian by whom the prescription was written, such directions as may be stated on the prescription, the serial number of the prescription, the date of filling or refilling and any cautionary statement in such prescription as may be required by law.
(c) When aqueous or oleaginous preparations are sold under subsection (c) of section 21a-250, a label shall be affixed to the container containing the preparation which bears the name, address and BNDD numbers of the vendor and vendee, the date of sale, the kind and quantity of substance sold and the serial number of the official written order. No person shall alter, deface or remove any label affixed pursuant to subsection (b) or this subsection.
(1967, P.A. 555, S. 19; 1972, P.A. 278, S. 11; P.A. 73-681, S. 10, 29; P.A. 82-419, S. 39, 47; P.A. 96-19, S. 3; P.A. 99-102, S. 36.)
History: 1972 act replaced “drug” with “substance” throughout section, made Subsec. (b) provisions applicable to podiatrists' prescriptions, required label to include prescription serial number, date of filing and necessary precautionary statements and deleted provision re label requirements for narcotic drugs, and replaced “registry” with “BNDD” numbers in Subsec. (c); P.A. 73-681 specified “aqueous or oleaginous” preparations in Subsec. (c); P.A. 82-419 amended Subsec. (b) to permit physician's last name only, rather than full name, on label and to change date of filing to date of filling or refilling; Sec. 19-463 transferred to Sec. 21a-256 in 1983; P.A. 96-19 expanded reference to prescriptions by physicians in Subsec. (b) to include advanced practice registered nurses and physician assistants; P.A. 99-102 amended Subsec. (b) by deleting obsolete references to osteopathy and making technical changes.

Structure Connecticut General Statutes

Connecticut General Statutes

Title 21a - Consumer Protection

Chapter 420b - Dependency-Producing Drugs

Section 21a-240. (Formerly Sec. 19-443). - Definitions.

Section 21a-241. (Formerly Sec. 19-449). - Prior regulations continued.

Section 21a-242. (Formerly Sec. 19-450a). - Schedules of controlled substances. Exceptions.

Section 21a-243. (Formerly Sec. 19-451). - Regulations. Schedules of controlled substances.

Section 21a-244. (Formerly Sec. 19-451a). - Regulations re storage and retrieval of prescription information.

Section 21a-244a. - Drug records maintained on electronic data processing systems or media systems. Electronic identifiers. Regulations.

Section 21a-245. (Formerly Sec. 19-452). - Manufacture, sale, administering of restricted substances regulated.

Section 21a-246. (Formerly Sec. 19-453). - License to manufacture, wholesale, supply, compound, etc. Exception. License fees. License to possess and supply marijuana.

Section 21a-247. (Formerly Sec. 19-454). - Qualifications of applicant for license.

Section 21a-248. (Formerly Sec. 19-456). - Sale or dispensing of controlled drugs by licensed manufacturer or wholesaler. Records; orders. Scope of uses limited.

Section 21a-249. (Formerly Sec. 19-457). - Prescription requirements.

Section 21a-250. (Formerly Sec. 19-458). - Rights and duties of pharmacist.

Section 21a-251. (Formerly Sec. 19-459). - Dispensing of controlled substances by hospitals, infirmaries or clinics.

Section 21a-252. (Formerly Sec. 19-460). - Prescription and dispensing of controlled substances by certain practitioners. Surrender of unused substances by patients. Prescription, dispensing and administering of controlled substances to immediate fam...

Section 21a-253. - Possession of marijuana pursuant to a prescription.

Section 21a-254. (Formerly Sec. 19-461). - Designation of restricted drugs or substances by regulations. Records required by chapter. Electronic prescription drug monitoring program. Information reporting of diabetes drugs and devices.

Section 21a-254a. - Appointment of prescription drug monitoring working group. Membership.

Section 21a-255. (Formerly Sec. 19-462). - Penalty for failure to make, furnish or keep records, statements or information. General penalty.

Section 21a-256. (Formerly Sec. 19-463). - Labeling of package or container of controlled substances.

Section 21a-257. (Formerly Sec. 19-464). - Person receiving narcotic drug to keep it in original container. Exceptions. Class D misdemeanor.

Section 21a-258. (Formerly Sec. 19-465). - Exceptions concerning possession and control.

Section 21a-259. (Formerly Sec. 19-466). - Common nuisances. Receivership of rental housing property development.

Section 21a-260. (Formerly Sec. 19-467a). - Narcotics control section in Department of Consumer Protection.

Section 21a-261. (Formerly Sec. 19-468). - Inspection of records. Entry on premises. Warrants and arrests.

Section 21a-262. (Formerly Sec. 19-469). - Commissioner's authority and duties re controlled substances. When seizing authority may destroy. Disposal by long-term care facilities, outpatient surgical facilities and home health care agencies.

Section 21a-263. (Formerly Sec. 19-469a). - Power of commissioner to receive and destroy drug paraphernalia. Records.

Section 21a-264. (Formerly Sec. 19-470). - Notice to licensing boards of violations by licensees.

Section 21a-265. (Formerly Sec. 19-471). - Inspection of prescriptions, orders, records and stocks restricted to government officers and third-party payors. Confidentiality.

Section 21a-266. (Formerly Sec. 19-472). - Prohibited acts.

Section 21a-267. (Formerly Sec. 19-472a). - Penalty for use, possession or delivery of drug paraphernalia associated with a controlled substance other than cannabis. Immunity.

Section 21a-268. (Formerly Sec. 19-473). - Misrepresentation of substance as controlled substance. Exemption.

Section 21a-269. (Formerly Sec. 19-474). - Burden of proof of exception, excuse, proviso or exemption.

Section 21a-270. (Formerly Sec. 19-474a). - Drug paraphernalia: Factors to be considered by court or other authority in determination.

Section 21a-271. (Formerly Sec. 19-474b). - Severability of provisions concerning drug paraphernalia.

Section 21a-272. (Formerly Sec. 19-475). - Preparations which may be sold and dispensed. Exceptions.

Section 21a-273. (Formerly Sec. 19-476). - Substances exempt under federal law.

Section 21a-274. (Formerly Sec. 19-477). - Cooperation in enforcement of law.

Section 21a-274a. - Drug enforcement grant program. Safe neighborhoods grant program. Community mobilization antidrug grant program.

Section 21a-275. (Formerly Sec. 19-478). - Revocation or suspension of licenses by commissioner.

Section 21a-276. (Formerly Sec. 19-479). - Discretion of commissioner to issue warning.

Section 21a-277. (Formerly Sec. 19-480). - Penalty for illegal manufacture, distribution, sale, prescription, dispensing.

Section 21a-278. (Formerly Sec. 19-480a). - Penalty for illegal manufacture, distribution, sale, prescription or administration by non-drug-dependent person.

Section 21a-278a. - Penalty for illegal manufacture, distribution, sale, prescription or administration.

Section 21a-278b. - Penalty for illegal manufacture, distribution, sale, prescription administration or growing of cannabis or cannabis products.

Section 21a-278c. - (Note: This section is effective July 1, 2023.) Cultivation of cannabis plants in consumer's primary residence.

Section 21a-279. (Formerly Sec. 19-481). - Penalty for illegal possession of a controlled substance other than cannabis. Alternative sentences. Immunity.

Section 21a-279a. - Limits for legal possession of cannabis. Penalty for illegal possession. Calculation of amount and equivalencies.

Section 21a-279b. - Construction of public act 15-2 of the June special session* re violations of section 21a-279.

Section 21a-279c. - Exceptions for seeking medical assistance for medical distress from use of cannabis.

Section 21a-279d. - Cannabis given by one consumer to another.

Section 21a-280. (Formerly Sec. 19-481a). - Breathing of anesthesia not violation.

Section 21a-281. (Formerly Sec. 19-481b). - Presumption of psychological dependence on volatile substances.

Section 21a-282. (Formerly Sec. 19-482). - No prosecution where federal action has been taken.

Section 21a-283. (Formerly Sec. 19-483). - Analytical tests for presence of controlled drugs or alcohol. Standards and procedures. Convictions constituting prior offense. Imposition of cost when analysis performed.

Section 21a-283a. - Court authorized to depart from imposing mandatory minimum sentence.

Section 21a-284 and 21a-285. (Formerly Secs. 19-484 and 19-485). - Suspension of prosecution for treatment for drug dependence; dismissal of charges. Order for treatment in addition to penalties on conviction; penalty for unauthorized departure from...

Section 21a-286. - Agreements for distribution and administration of opioid antagonists. Regulations.

Section 21a-254. (Formerly Sec. 19-461). *(See end of section for - Designation of restricted drugs or substances by regulations. Records required by chapter. Electronic prescription drug monitoring program. Information reporting of diabetes drugs an...

Section 21a-301 to 21a-305. (Formerly Secs. 19-504a, 19-504c to 19-504e, - Definitions. Regulations. Inspections of: Institutional pharmacies, pharmacist's drug rooms and dispensing outpatient facilities; correctional and juvenile training institutio...

Section 21a-307. (Formerly Sec. 19-504i). - Definitions re dispensing of drugs.